Skip to content

Dynatron Tri-Wave Light Probe DCP3

by Dynatronics Corp.

Dynatron Tri-Wave Light Probe DCP3 is a Class II device made by Dynatronics Corp., cleared under FDA 510(k) K113250 on 9 Feb 2012 and listed in FDA GUDID since 24 Sep 2016 (UDI-DI 10660584000154), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

510(k) K113250

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number10660584000154 UDI-DI Date24 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK113250 Date9 Feb 2012DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K113250 decided 9 Feb 2012 Active
  • FDA GUDID UDI-DI 10660584000154 listed 24 Sep 2016 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K113250
  2. Listed FDA GUDID 10660584000154

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Dynatron Tri-Wave Light Probe
Generic name
Light-energy skin surface treatment system applicator
Model / reference
DCP3
Primary DI / UDI-DI
10660584000154
510(k) Number
FDA product code
ILY
GMDN term
Light-energy skin surface treatment system applicator
Device class
Class II
Regulation number
890.5500
GUDID distribution status
In Commercial Distribution
Size
Weight — 0.6 Pound

Similar devices in this category

Other devices filed under Light-energy skin surface treatment system applicator.

Other devices from Dynatronics Corp.

See all devices from Dynatronics Corp. →

Properties

  • Prescription use
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)